Sining Liu - Institute of Blood and Marrow Transplantation, Soochow University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Rituximab Improves Clinical Outcomes of CAR-T Therapy for R/r B-ALL Via Sensitizing Leukemia Cells to CAR-T-Mediated Cytotoxicity and Reducing CAR-T Exhaustion

Yangzi Li,Qingya Cui,Sining Liu,Lingling Liu,Megyn Li,Jun Gao,Zheng Li,Wei Cui,Xiaming Zhu,Liqing Kang,Lei Yu,Depei Wu,Xiaowen Tang

CELLULAR ONCOLOGYno. 5 (2024): 1649-1661

引用0浏览0WOS引用

Decitabine Consolidation after CD19/CD22 CAR-T Therapy As a Novel Maintenance Treatment Significantly Improves Survival Outcomes in Relapsed/refractory B-ALL Patients

Tingting Li,Qingya Cui,Sining Liu,Zheng Li, Wei Cui,Mengyun Li,Yunju Ma,Xuanqi Cao,Xiaming Zhu,Liqing Kang,Lei Yu,Depei Wu,Xiaowen Tang

Leukemia Researchpp.107569, (2024)

引用0浏览0WOS引用

P357: DECITABINE CONSOLIDATION AFTER CD19/CD22 CAR-T THERAPY IS A NOVEL STRATEGY TO IMPROVE OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Tingting LI,Qingya Cui,Sining Liu,Zheng LI, Wei Cui,Mengyun LI,Xiaming Zhu,Liqing Kang,Lei Yu,Depei Wu,Xiaowen Tang

HemaSphereno. S3 (2023)

引用0浏览0引用

Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia

Sining Liu,Qingya Cui,Zheng Li, Wei Cui,Mengyun Li,Huiying Qiu,Shengli Xue,Suning Chen,Zhengming Jin, Miao,Yue Han,Ying Wang,Xiaming Zhu,Lei Yu,Depei Wu,Xiaowen Tang

Bloodno. Supplement 1 (2023): 3491-3491

引用0浏览0引用

Additional File 5 of Decitabine in Combination with Fludarabine and Cyclophosphamide As a Lymphodepletion Regimen Followed by CD19/CD22 Bispecific Targeted CAR T-cell Therapy Significantly Improves Survival in Relapsed/refractory B-ALL Patients

Yunju Ma, Haiping Dai,Qingya Cui,Sining Liu,Liqing Kang, Xiaying Lian, Wei Cui,Jia Yin,Lingling Liu, Cai Min,Yu Liu,Depei Wu,Xiaowen Tang

Figshare (2023)

引用0浏览0引用

Long‐term Follow‐up of Tandem CD19/CD22 CAR T‐Cells in R/r B‐ALL Patients with High‐risk Features

Wei Cui,Xin‐Yue Zhang,Zheng Li,Haiping Dai,Jia Yin,Qingya Cui,Sining Liu,Liqing Kang,Lei Yu,Depei Wu,Xiaowen Tang

American journal of hematologyno. 11 (2023)

引用0浏览0引用

Decitabine in Combination with Fludarabine and Cyclophosphamide As a Lymphodepletion Regimen Followed by CD19/CD22 Bispecific Targeted CAR T-cell Therapy Significantly Improves Survival in Relapsed/refractory B-ALL Patients

Yunju Ma, Haiping Dai,Qingya Cui,Sining Liu,Liqing Kang, Xiaying Lian, Wei Cui,Jia Yin,Lingling Liu,Mengjie Cai,Lei Yu,Depei Wu,Xiaowen Tang

Experimental Hematology & Oncologyno. 1 (2023)

引用0浏览0引用

CAR-based Cellular Therapy - Clinical

Qingya Cui,Sining Liu,Nan Xu,Liqing Kang, Haiping Dai, Wei Cui,Baoquan Song,Jia Yin,Zheng Li,Xiaming Zhu,Tianhui Liu,Wenhong Shen,Mingqing Zhu,Lei Yu,Depei Wu,Xiaowen Tang

BONE MARROW TRANSPLANTATIONno. SUPP1 (2023): 42-43

引用0浏览0引用

Efficacy and Safety of Mesenchymal Stem Cells Treatment for Multidrug-Resistant Graft-Versus-host Disease after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Meng-Zhu Shen,Xin-Xin Liu, Zhi-Yuan Qiu,Lan-Ping Xu,Xiao-Hui Zhang,Yu Wang,Chen-Hua Yan,Huan Chen,Yu-Hong Chen, Wei Han,Feng-Rong Wang,Jing-Zhi Wang,Si-Ning Liu,Kai-Yan Liu,Xiao-Jun Huang,Xiao-Dong Mo

Therapeutic Advances in Hematology（2022）

引用6浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn